Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001437749-25-021373

Options or other derivatives

  • Director acquired 14,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Boyce Sarah · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-26 Grant or award : show line 1 in the form Stock Option (right to buy) +14,750 14,750 D
Loading xslF345X05/rdgdoc.xml…